The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 04, 2018
Filed:
Jun. 01, 2015
Chdi Foundation, Inc., New York, NY (US);
Celia Dominguez, Los Angeles, CA (US);
Ignacio Muñoz-Sanjuán, Los Angeles, CA (US);
Roland W. Bürli, Saffron Walden, GB;
Christopher A. Luckhurst, Saffron Walden, GB;
Daniel R. Allen, Saffron Walden, GB;
Gilles Raphy, Saffron Walden, GB;
Perla Breccia, Saffron Walden, GB;
Alan F. Haughan, Saffron Walden, GB;
Grant Wishart, Saffron Walden, GB;
Samantha J. Hughes, Saffron Walden, GB;
Rebecca E. Jarvis, Saffron Walden, GB;
Huw D. Vater, Saffron Walden, GB;
Stephen D. Penrose, Saffron Walden, GB;
Michael Wall, Saffron Walden, GB;
Andrew J. Stott, Saffron Walden, GB;
Elizabeth A. Saville-Stones, Saffron Walden, GB;
CHDI Foundation, Inc., New York, NY (US);
Abstract
Provided are certain histone deacetylase (HDAC) inhibitors of Formula I, or pharmaceutically acceptable salts thereof, compositions thereof, and methods of their use. The condition or disorder mediated by HDAC comprises a neurodegenerative pathology. Accordingly, also provided is a method of treating a neurodegenerative pathology mediated by HDAC in a subject in need of such a treatment, comprising administering to the subject a therapeutically effective amount of at least one compound, or pharmaceutically acceptable salt thereof, described herein.